Primary Immunodeficiency

Immunology·MeSH: Primary Immunodeficiency Diseases

16 drugs in development·4 companies·1 clinical trial

Drug Pipeline by Phase

Approved(7)

Drug	Company
ASCENIV	ADMA BIOLOGICS, INC. (ADMA)
BIVIGAM	ADMA BIOLOGICS, INC. (ADMA)
cutaquig	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
cuvitru	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
gammagard liquid	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
hizentra	KORU Medical Systems Inc. Common Stock (DE) (KRMD)
xembify	KORU Medical Systems Inc. Common Stock (DE) (KRMD)

Phase 3(8)

Drug	Company
hyqvia	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
hyqvia	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
immune globulin	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-771	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-771	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-881	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-881	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-881	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

Phase 4(1)

Drug	Company
immune globulin	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

BioSniper tracks 16 drugs in development for Primary Immunodeficiency across 4 companies.

There are 1 clinical trial targeting Primary Immunodeficiency tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.